FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, specifically to a method for identifying functional M1 and M2 phenotype of human macrophages generated in vitro from blood monocytes. Proposed method consists in evaluating the effect of cells produced by culturing monocytes in the presence of M1- or M2-polarizing stimuli on a proliferative response of T-lymphocytes in a mixed culture of leukocytes.
EFFECT: method enables to identify M1 and M2 human macrophages with high accuracy.
4 cl, 6 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR IMMUNE THERAPY OF CHRONIC VIRAL HEPATITIS C | 2016 |
|
RU2637631C2 |
| METHOD OF SELECTING MEDICINAL PRODUCTS FOR PHARMACOLOGICAL INDUCTION OF MITOCHONDRIAL DYSFUNCTION IN MACROPHAGES FOR ANTITUMOR THERAPY | 2023 |
|
RU2810558C1 |
| MACROPHAGE ACTIVATION MODULATION | 2012 |
|
RU2639553C2 |
| BTN2-SPECIFIC ANTIBODIES AND USE THEREOF | 2020 |
|
RU2821703C2 |
| MEDICAMENT FOR SUPPRESSING INFECTION AND HUMAN IMMUNE DEFICIENCY VIRUS PROLIFERATION | 2002 |
|
RU2250770C2 |
| DENDRITIC CELL GENERATION FROM MONOCYTIC DENDRITIC CELL PRE-CURSORS BY MEANS OF GM-CSF IN ABSENCE OF ADDITIONAL CYTOKINES | 2004 |
|
RU2364625C2 |
| METHOD OF ENHANCEMENT OF IMMUNE RESPONSE TO ANTIGENE IN MAMMALS | 2004 |
|
RU2341289C2 |
| METHOD FOR TUMOUR GROWTH INHIBITION IN EXPERIMENT | 2015 |
|
RU2599438C1 |
| METHOD OF TUMOUR GROWTH INHIBITION BASED ON IN VITRO REPROGRAMMING MACROPHAGES ON M1 PHENOTYPE WITH HIGH ABILITY OF NITRIC OXIDE PRODUCTION IN EXPERIMENT | 2015 |
|
RU2599545C1 |
| METHOD OF SUPPRESSION OF INFLAMMATORY RESPONSE IN PERIODONTAL TISSUES IN AN EXPERIMENT | 2017 |
|
RU2677642C1 |
